Tapewire

NYSE · USD

SDEV

Stablecoin Development Corp

Export transactions ↓
Tapewire entity
7283
SEC CIK
0001389545
Parsed reports
170

Last 12 months

Inside the activity.

0 purchase rows · 3 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202603
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 11, 2023 Filed May 15, 2023 22:52 UTC Exercise / conversionCommon Stock 858 Not disclosed Not disclosed
Disclosure

SEC source: 0001437749-23-014700 · rdgdoc.xml · nonDerivative · entry 1

Zheng Yongxiang · CIK 0001910375 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 858

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On November 15, 2022, NovaBay Pharmaceuticals, Inc. effected a 1-for-35 reverse stock split of its common stock, which is reflected in the number of shares.

F2 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested on the one year anniversary of the date of grant.

F1 · balance_after: On November 15, 2022, NovaBay Pharmaceuticals, Inc. effected a 1-for-35 reverse stock split of its common stock, which is reflected in the number of shares.

Read SEC document
December 06, 2022 Filed Dec 7, 2022 21:55 UTC
Kunin AudreyChief Product Officer
SaleCommon Stock 1 $1.81 $1.81
Disclosure

SEC source: 0001437749-22-028673 · rdgdoc.xml · nonDerivative · entry 1

Kunin Audrey · CIK 0001738781 · Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

F1 · ownership.nature: By The Audrey G. Kunin Trust in which the reporting person serves as the trustee and has investment control.

Read SEC document
December 06, 2022 Filed Dec 7, 2022 21:55 UTC
Kunin JeffreyPresident, DERMAdoctor, LLC
SaleCommon Stock 1 $1.81 $1.81
Disclosure

SEC source: 0001437749-22-028672 · rdgdoc.xml · nonDerivative · entry 1

Kunin Jeffrey · CIK 0001738782 · President, DERMAdoctor, LLC

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

F1 · ownership.nature: By The Audrey G. Kunin Trust in which the reporting person's spouse serves as the trustee and has investment control.

Read SEC document
November 21, 2022 Filed Nov 23, 2022 21:16 UTC
Kunin AudreyDirector · Chief Product Officer
SaleCommon Stock 5,960 $2.10 $12,545.20
Disclosure

SEC source: 0001437749-22-028031 · rdgdoc.xml · nonDerivative · entry 1

Kunin Audrey · CIK 0001738781 · Director · Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

F1 · shares: On November 15, 2022, the common stock of NovaBay Pharmaceuticals, Inc. split 1-for-35, and is reflected accordingly in the number of shares sold.

F2 · price: This transaction was executed in multiple trades at prices ranging from $2.09 to $2.12. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3 · ownership.nature: By The Audrey G. Kunin Trust in which the reporting person serves as the trustee and has investment control.

Read SEC document
November 21, 2022 Filed Nov 23, 2022 21:15 UTC
Kunin JeffreyPresident, DERMAdoctor, LLC
SaleCommon Stock 5,960 $2.10 $12,545.20
Disclosure

SEC source: 0001437749-22-028029 · rdgdoc.xml · nonDerivative · entry 1

Kunin Jeffrey · CIK 0001738782 · President, DERMAdoctor, LLC

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

F1 · shares: On November 15, 2022, the common stock of NovaBay Pharmaceuticals, Inc. split 1-for-35, and is reflected accordingly in the number of shares sold.

F2 · price: This transaction was executed in multiple trades at prices ranging from $2.09 to $2.12. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3 · ownership.nature: By The Audrey G. Kunin Trust in which the reporting person's spouse serves as the trustee and has investment control.

Read SEC document
November 21, 2022 Filed Dec 5, 2022 22:30 UTC Amendment
Kunin AudreyChief Product Officer
SaleCommon Stock 5,960 $2.10 $12,545.20
Disclosure

SEC source: 0001437749-22-028439 · rdgdoc.xml · nonDerivative · entry 1

Kunin Audrey · CIK 0001738781 · Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1

F1 · shares: On November 15, 2022, the common stock of NovaBay Pharmaceuticals, Inc. split 1-for-35, and is reflected accordingly in the number of shares sold.

F2 · price: This transaction was executed in multiple trades at prices ranging from $2.09 to $2.12. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3 · balance_after: The original Form 4, filed on November 23, 2022, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported that the reporting person beneficially owned no shares following the reported transaction when in fact the reporting person beneficially owned one share following the reported transaction.

F4 · ownership.nature: By The Audrey G. Kunin Trust in which the reporting person serves as the trustee and has investment control.

Read SEC document
November 21, 2022 Filed Dec 5, 2022 22:30 UTC Amendment
Kunin JeffreyPresident, DERMAdoctor, LLC
SaleCommon Stock 5,960 $2.10 $12,545.20
Disclosure

SEC source: 0001437749-22-028438 · rdgdoc.xml · nonDerivative · entry 1

Kunin Jeffrey · CIK 0001738782 · President, DERMAdoctor, LLC

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1

F1 · shares: On November 15, 2022, the common stock of NovaBay Pharmaceuticals, Inc. split 1-for-35, and is reflected accordingly in the number of shares sold.

F2 · price: This transaction was executed in multiple trades at prices ranging from $2.09 to $2.12. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3 · balance_after: The original Form 4, filed on November 23, 2022, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported that the reporting person beneficially owned no shares following the reported transaction when in fact the reporting person beneficially owned one share following the reported transaction.

F4 · ownership.nature: By The Audrey G. Kunin Trust in which the reporting person's spouse serves as the trustee and has investment control.

Read SEC document
September 14, 2022 Filed Sep 17, 2022 00:45 UTC
Hall JustinDirector · CEO, GC and Director
PurchaseCommon Stock 10,000 $0.15 $1,500.00
Disclosure

SEC source: 0001437749-22-022651 · rdgdoc.xml · nonDerivative · entry 1

Hall Justin · CIK 0001663021 · Director · CEO, GC and Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,172

Read SEC document
September 14, 2022 Filed Sep 16, 2022 22:26 UTC
Kunin JeffreyPresident, DERMAdoctor, LLC
SaleCommon Stock 291,368 $0.16 $46,094.42
Disclosure

SEC source: 0001437749-22-022648 · rdgdoc.xml · nonDerivative · entry 1

Kunin Jeffrey · CIK 0001738782 · President, DERMAdoctor, LLC

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 208,632

F1 · price: This transaction was executed in multiple trades at prices ranging from $0.1565 to $0.1605. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2 · ownership.nature: By The Audrey G. Kunin Trust in which the reporting person's spouse serves as the trustee and has investment control.

Read SEC document
September 14, 2022 Filed Sep 16, 2022 22:24 UTC
Kunin AudreyDirector · Chief Product Officer
SaleCommon Stock 291,368 $0.16 $46,094.42
Disclosure

SEC source: 0001437749-22-022646 · rdgdoc.xml · nonDerivative · entry 1

Kunin Audrey · CIK 0001738781 · Director · Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 208,632

F1 · price: This transaction was executed in multiple trades at prices ranging from $0.1565 to $0.1605. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2 · ownership.nature: By The Audrey G. Kunin Trust in which the reporting person serves as the trustee and has investment control.

Read SEC document
May 21, 2022 Filed May 24, 2022 23:30 UTC Exercise / conversionRestricted Stock Units · Derivative 30,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-22-013459 · rdgdoc.xml · derivative · entry 3

Freiman Paul E. · CIK 0001410074 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested on the one year anniversary of the date of grant.

F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested on the one year anniversary of the date of grant.

F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested on the one year anniversary of the date of grant.

Read SEC document
May 21, 2022 Filed May 24, 2022 23:30 UTC Exercise / conversionCommon Stock 30,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001437749-22-013459 · rdgdoc.xml · nonDerivative · entry 1

Freiman Paul E. · CIK 0001410074 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested on the one year anniversary of the date of grant.

Read SEC document
May 21, 2022 Filed May 24, 2022 23:31 UTC
Zheng YenyouDirector
Exercise / conversionRestricted Stock Units · Derivative 30,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-22-013460 · rdgdoc.xml · derivative · entry 2

Zheng Yenyou · CIK 0001330748 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested on the one year anniversary of the date of grant.

F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested on the one year anniversary of the date of grant.

F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested on the one year anniversary of the date of grant.

Read SEC document
May 21, 2022 Filed May 24, 2022 23:31 UTC
Zheng YenyouDirector
Exercise / conversionCommon Stock 30,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001437749-22-013460 · rdgdoc.xml · nonDerivative · entry 1

Zheng Yenyou · CIK 0001330748 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested on the one year anniversary of the date of grant.

Read SEC document
May 21, 2022 Filed May 24, 2022 23:33 UTC
WU MIJIADirector
Exercise / conversionRestricted Stock Units · Derivative 30,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-22-013461 · rdgdoc.xml · derivative · entry 2

WU MIJIA · CIK 0001664299 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested on the one year anniversary of the date of grant.

F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested on the one year anniversary of the date of grant.

F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested on the one year anniversary of the date of grant.

Read SEC document
May 21, 2022 Filed May 24, 2022 23:33 UTC
WU MIJIADirector
Exercise / conversionCommon Stock 30,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001437749-22-013461 · rdgdoc.xml · nonDerivative · entry 1

WU MIJIA · CIK 0001664299 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested on the one year anniversary of the date of grant.

Read SEC document
May 21, 2022 Filed May 24, 2022 23:28 UTC
Sit SwanDirector
Exercise / conversionRestricted Stock Units · Derivative 30,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-22-013458 · rdgdoc.xml · derivative · entry 2

Sit Swan · CIK 0001801128 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested on the one year anniversary of the date of grant.

F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested on the one year anniversary of the date of grant.

F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested on the one year anniversary of the date of grant.

Read SEC document
May 21, 2022 Filed May 24, 2022 23:28 UTC
Sit SwanDirector
Exercise / conversionCommon Stock 30,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001437749-22-013458 · rdgdoc.xml · nonDerivative · entry 1

Sit Swan · CIK 0001801128 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested on the one year anniversary of the date of grant.

Read SEC document
May 11, 2022 Filed May 14, 2022 00:31 UTC GrantRestricted Stock Units · Derivative 30,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-22-012433 · rdgdoc.xml · derivative · entry 1

Freiman Paul E. · CIK 0001410074 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant.

F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant.

F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant.

Read SEC document
May 11, 2022 Filed May 14, 2022 00:32 UTC
Zheng YenyouDirector
GrantRestricted Stock Units · Derivative 30,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-22-012435 · rdgdoc.xml · derivative · entry 1

Zheng Yenyou · CIK 0001330748 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant.

F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant.

F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant.

Read SEC document
May 11, 2022 Filed May 14, 2022 00:32 UTC GrantRestricted Stock Units · Derivative 30,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-22-012436 · rdgdoc.xml · derivative · entry 1

Zheng Yongxiang · CIK 0001910375 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant.

F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant.

F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant.

Read SEC document
May 11, 2022 Filed May 14, 2022 00:33 UTC
WU MIJIADirector
GrantRestricted Stock Units · Derivative 30,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-22-012438 · rdgdoc.xml · derivative · entry 1

WU MIJIA · CIK 0001664299 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant.

F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant.

F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant.

Read SEC document
May 11, 2022 Filed May 14, 2022 00:33 UTC
Sit SwanDirector
GrantRestricted Stock Units · Derivative 30,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-22-012437 · rdgdoc.xml · derivative · entry 1

Sit Swan · CIK 0001801128 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant.

F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant.

F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant.

Read SEC document
May 11, 2022 Filed May 14, 2022 00:31 UTC GrantRestricted Stock Units · Derivative 30,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-22-012434 · rdgdoc.xml · derivative · entry 1

Garlikov Julie · CIK 0001793266 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant.

F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant.

F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant.

Read SEC document
December 06, 2021 Filed Dec 7, 2021 01:03 UTC
Hall JustinDirector · CEO, GC and Director
PurchaseCommon Stock 69,767 $0.43 $29,999.81
Disclosure

SEC source: 0001437749-21-027958 · rdgdoc.xml · nonDerivative · entry 1

Hall Justin · CIK 0001663021 · Director · CEO, GC and Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,172

Read SEC document
December 06, 2021 Filed Dec 6, 2021 21:30 UTC PurchaseCommon Stock 36,765 $0.44 $16,176.60
Disclosure

SEC source: 0001437749-21-027933 · rdgdoc.xml · nonDerivative · entry 2

Jones Andrew D. · CIK 0001811872 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 127,461

Read SEC document
December 03, 2021 Filed Dec 6, 2021 21:30 UTC PurchaseCommon Stock 8,690 $0.44 $3,823.60
Disclosure

SEC source: 0001437749-21-027933 · rdgdoc.xml · nonDerivative · entry 1

Jones Andrew D. · CIK 0001811872 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,696

Read SEC document
December 03, 2021 Filed Dec 7, 2021 22:43 UTC
Kunin AudreyChief Product Officer
PurchaseCommon Stock 101,650 $0.46 $47,013.13
Disclosure

SEC source: 0001437749-21-028027 · rdgdoc.xml · nonDerivative · entry 1

Kunin Audrey · CIK 0001738781 · Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 500,000

F1 · price: This transaction was executed in multiple trades at prices ranging from $0.4600 to $0.4650. The price reported above reflected the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2 · ownership.nature: By The Audrey G. Kunin Trust in which the reporting person serves as the trustee and has investment control.

Read SEC document
December 03, 2021 Filed Dec 7, 2021 22:46 UTC
Kunin JeffreyPresident, DERMAdoctor, LLC
PurchaseCommon Stock 101,650 $0.46 $47,013.13
Disclosure

SEC source: 0001437749-21-028029 · rdgdoc.xml · nonDerivative · entry 1

Kunin Jeffrey · CIK 0001738782 · President, DERMAdoctor, LLC

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 500,000

F1 · price: This transaction was executed in multiple trades at prices ranging from $0.4600 to $0.4650. The price reported above reflected the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2 · ownership.nature: By The Audrey G. Kunin Trust in which the reporting person's spouse serves as the trustee and has investment control.

Read SEC document
December 02, 2021 Filed Dec 6, 2021 21:31 UTC
Kunin JeffreyPresident, DERMAdoctor, LLC
PurchaseCommon Stock 262,369 $0.48 $124,887.64
Disclosure

SEC source: 0001437749-21-027935 · rdgdoc.xml · nonDerivative · entry 1

Kunin Jeffrey · CIK 0001738782 · President, DERMAdoctor, LLC

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 398,350

F1 · price: This transaction was executed in multiple trades at prices ranging from $0.4650 to $0.4900. The price reported above reflected the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2 · ownership.nature: By The Audrey G. Kunin Trust in which the reporting person's spouse serves as the trustee and has investment control.

Read SEC document
December 02, 2021 Filed Dec 6, 2021 21:31 UTC
Kunin AudreyChief Product Officer
PurchaseCommon Stock 262,369 $0.48 $124,887.64
Disclosure

SEC source: 0001437749-21-027934 · rdgdoc.xml · nonDerivative · entry 1

Kunin Audrey · CIK 0001738781 · Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 398,350

F1 · price: This transaction was executed in multiple trades at prices ranging from $0.4650 to $0.4900. The price reported above reflected the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2 · ownership.nature: By The Audrey G. Kunin Trust in which the reporting person serves as the trustee and has investment control.

Read SEC document
December 01, 2021 Filed Dec 3, 2021 21:30 UTC
Kunin AudreyChief Product Officer
PurchaseCommon Stock 14,848 $0.49 $7,275.52
Disclosure

SEC source: 0001437749-21-027852 · rdgdoc.xml · nonDerivative · entry 1

Kunin Audrey · CIK 0001738781 · Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 135,981

F1 · ownership.nature: By The Audrey G. Kunin Trust in which the reporting person serves as the trustee and has investment control.

Read SEC document
December 01, 2021 Filed Dec 3, 2021 21:30 UTC
Kunin JeffreyPresident, DERMAdoctor, LLC
PurchaseCommon Stock 14,848 $0.49 $7,275.52
Disclosure

SEC source: 0001437749-21-027850 · rdgdoc.xml · nonDerivative · entry 1

Kunin Jeffrey · CIK 0001738782 · President, DERMAdoctor, LLC

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 135,981

F1 · ownership.nature: By The Audrey G. Kunin Trust in which the reporting person's spouse serves as the trustee and has investment control.

Read SEC document
November 30, 2021 Filed Dec 2, 2021 21:30 UTC
Kunin JeffreyPresident, DERMAdoctor, LLC
PurchaseCommon Stock 30,000 $0.46 $13,800.00
Disclosure

SEC source: 0001437749-21-027708 · rdgdoc.xml · nonDerivative · entry 1

Kunin Jeffrey · CIK 0001738782 · President, DERMAdoctor, LLC

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 121,133

F1 · ownership.nature: By The Audrey G. Kunin Trust in which the reporting person's spouse serves as the trustee and has investment control.

Read SEC document
November 30, 2021 Filed Dec 2, 2021 21:30 UTC
Kunin AudreyChief Product Officer
PurchaseCommon Stock 30,000 $0.46 $13,800.00
Disclosure

SEC source: 0001437749-21-027706 · rdgdoc.xml · nonDerivative · entry 1

Kunin Audrey · CIK 0001738781 · Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 121,133

F1 · ownership.nature: By The Audrey G. Kunin Trust in which the reporting person serves as the trustee and has investment control.

Read SEC document
November 23, 2021 Filed Nov 24, 2021 21:46 UTC
Kunin AudreyChief Product Officer
PurchaseCommon Stock 66,133 $0.46 $30,368.27
Disclosure

SEC source: 0001437749-21-027397 · rdgdoc.xml · nonDerivative · entry 2

Kunin Audrey · CIK 0001738781 · Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · see footnote

Disclosed balance after: 91,133

F1 · price: This transaction was executed in multiple trades at prices ranging from $0.4545 to $0.4610. The price reported above reflected the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2 · ownership.nature: By The Audrey G. Kunin Trust in which the reporting person serves as the trustee and has investment control.

Read SEC document
November 23, 2021 Filed Nov 24, 2021 21:46 UTC
Kunin JeffreyPresident, DERMAdoctor, LLC
PurchaseCommon Stock 66,133 $0.46 $30,368.27
Disclosure

SEC source: 0001437749-21-027396 · rdgdoc.xml · nonDerivative · entry 2

Kunin Jeffrey · CIK 0001738782 · President, DERMAdoctor, LLC

10b5-1 filing: Not disclosed

Ownership: Indirect · see footnote

Disclosed balance after: 91,133

F1 · price: This transaction was executed in multiple trades at prices ranging from $0.4545 to $0.4610. The price reported above reflected the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2 · ownership.nature: By The Audrey G. Kunin Trust in which the reporting person's spouse serves as the trustee and has investment control.

Read SEC document
November 22, 2021 Filed Nov 24, 2021 21:46 UTC
Kunin AudreyChief Product Officer
PurchaseCommon Stock 25,000 $0.46 $11,500.00
Disclosure

SEC source: 0001437749-21-027397 · rdgdoc.xml · nonDerivative · entry 1

Kunin Audrey · CIK 0001738781 · Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · see footnote

Disclosed balance after: 25,000

F2 · ownership.nature: By The Audrey G. Kunin Trust in which the reporting person serves as the trustee and has investment control.

Read SEC document
November 22, 2021 Filed Nov 24, 2021 21:46 UTC
Kunin JeffreyPresident, DERMAdoctor, LLC
PurchaseCommon Stock 25,000 $0.46 $11,500.00
Disclosure

SEC source: 0001437749-21-027396 · rdgdoc.xml · nonDerivative · entry 1

Kunin Jeffrey · CIK 0001738782 · President, DERMAdoctor, LLC

10b5-1 filing: Not disclosed

Ownership: Indirect · see footnote

Disclosed balance after: 25,000

F2 · ownership.nature: By The Audrey G. Kunin Trust in which the reporting person's spouse serves as the trustee and has investment control.

Read SEC document
May 21, 2021 Filed May 25, 2021 20:47 UTC GrantRestricted Stock Unit · Derivative 30,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-21-013297 · rdgdoc.xml · derivative · entry 1

Freiman Paul E. · CIK 0001410074 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common stock · 30,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant.

F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant.

F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant.

Read SEC document
May 21, 2021 Filed May 25, 2021 20:46 UTC
Zheng YenyouDirector
GrantRestricted Stock Unit · Derivative 30,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-21-013293 · rdgdoc.xml · derivative · entry 1

Zheng Yenyou · CIK 0001330748 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common stock · 30,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant.

F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant.

F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant.

Read SEC document
May 21, 2021 Filed May 25, 2021 20:47 UTC
WU MIJIADirector
GrantRestricted Stock Unit · Derivative 30,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-21-013296 · rdgdoc.xml · derivative · entry 1

WU MIJIA · CIK 0001664299 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant.

F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant.

F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant.

Read SEC document
May 21, 2021 Filed May 25, 2021 20:46 UTC
Sit SwanDirector
GrantRestricted Stock Unit · Derivative 30,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-21-013295 · rdgdoc.xml · derivative · entry 1

Sit Swan · CIK 0001801128 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common stock · 30,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant.

F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant.

F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant.

Read SEC document
May 21, 2021 Filed May 25, 2021 20:46 UTC
Li XinzhouDirector · 10% owner
GrantRestricted Stock Unit · Derivative 30,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-21-013294 · rdgdoc.xml · derivative · entry 1

Li Xinzhou · CIK 0001565534 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common stock · 30,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant.

F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant.

F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant.

Read SEC document
May 04, 2021 Filed May 7, 2021 22:00 UTC Tax withholdingCommon Stock 77,994 $0.79 $61,833.64
Disclosure

SEC source: 0001437749-21-011378 · rdgdoc.xml · nonDerivative · entry 1

Jones Andrew D. · CIK 0001811872 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,006

F1 · security: Represents payment of tax liability due to vesting of 160,000 time-based restricted stock units (as previously reported on Mr. Jones' Form 3, as filed with the SEC on May 13, 2020).

Read SEC document
August 20, 2020 Filed Aug 24, 2020 16:49 UTC
Xu WangNEO - Sr Mgr and Controller
GrantStock Option (right to buy) · Derivative 75,000 $0.00 Strike: $0.99 $0.00
Disclosure

SEC source: 0001437749-20-018610 · rdgdoc.xml · derivative · entry 1

Xu Wang · CIK 0001807054 · NEO - Sr Mgr and Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2030-08-20

F1 · derivative.exercise_date: The stock option grant will vest over four years, with 25% vesting on the first anniversary of the grant date and 6.25% vesting very three months thereafter.

Read SEC document
August 20, 2020 Filed Aug 24, 2020 20:49 UTC GrantStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $0.99 $0.00
Disclosure

SEC source: 0001437749-20-018608 · rdgdoc.xml · derivative · entry 1

Jones Andrew D. · CIK 0001811872 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2030-08-20

F1 · derivative.exercise_date: The stock option grant will vest over four years, with 25% vesting on the first anniversary of the grant date and 6.25% vesting very three months thereafter.

Read SEC document
August 20, 2020 Filed Aug 24, 2020 20:49 UTC
Hall JustinCEO and GC
GrantStock Option (right to buy) · Derivative 350,000 $0.00 Strike: $0.99 $0.00
Disclosure

SEC source: 0001437749-20-018607 · rdgdoc.xml · derivative · entry 1

Hall Justin · CIK 0001663021 · CEO and GC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 350,000

Underlying: Common stock · 350,000 shares

Expires 2030-08-20

F1 · derivative.exercise_date: The stock option grant will vest over four years, with 25% vesting on the first anniversary of the grant date and 6.25% vesting very three months thereafter.

Read SEC document
August 17, 2020 Filed Aug 19, 2020 20:24 UTC
WU MIJIADirector
OtherStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $0.30 $0.00
Disclosure

SEC source: 0001437749-20-018340 · rdgdoc.xml · derivative · entry 3

WU MIJIA · CIK 0001664299 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common stock · 20,000 shares

Expires 2029-05-30

Read SEC document
August 17, 2020 Filed Aug 19, 2020 20:24 UTC
WU MIJIADirector
SaleCommon stock 20,000 $1.35 $27,000.00
Disclosure

SEC source: 0001437749-20-018340 · rdgdoc.xml · nonDerivative · entry 2

WU MIJIA · CIK 0001664299 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.